Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL1418100-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI M701TVIL1418100J1), received between Mar 3, 2016 and Nov 10, 2023 — classified as 6 injuries.
The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Improper or Incorrect Procedure or Method2
- Adverse Event Without Identified Device or Use Problem1
- Insufficient Device Problem Information1
- Lack of Effect1
- Malposition of Device1
- Migration1
- Occlusion Within Device1
- Off-Label Use1
Patient problems
- Aneurysm2
- Failure of Implant2
- Occlusion2
- Abdominal Pain1
- Clinical Endoleak1
- Paralysis1
- Rupture1
- Stroke/CVA1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryNov 10, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
THE PATIENT WAS TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE IMPLANT OF THE ALTO ABDOMINAL STENT GRAFT SYSTEM (LEFT LIMB: LOT: FS031221-09, RIGHT LIMB: LOT: FS020121-29) ON (B)(6) 2022. REPORTEDLY, ON (B)(6) 2022, THE PATIENT FELT PARALYZED ON THEIR RIGHT LOWER LIMB, AND VISITED THE LOCAL HOSPITAL ON THE NEXT DAY. THE PATIENT WAS ADMITTED TO THE HOSPITAL. REPORTEDLY, THE PATIENT EXPERIENCED BRAIN INFARCTION AND UNKNOWN TREATMENT WAS PROVIDED. THE CAUSE OF THE BRAIN INFARCTION IS UNKNOWN. THE PATIENT WAS REPORTED TO BE BETTER THE FOLLOWING MONTH.
Patient problems: Paralysis; Stroke/CVA
MAUDE report 18114375 ↗InjuryMay 30, 2023Lack of Effect; Lack of Effect
THE PATIENT WAS IMPLANTED WITH THE OVATION IX STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY SEVEN (7) YEARS POST INITIAL PROCEDURE THE PATIENT PRESENTED AT THE EMERGENCY ROOM WITH ABDOMINAL AND BACK PAIN. THE PATIENT HAD BEEN LOST TO FOLLOW UP AND WAS LAST SEEN IN 2019. CURRENTLY THE AAA MEASURES 18CM AND THERE IS A CONTAINED RUPTURE DUE TO A RIGHT COMMON ILIAC ARTERY (CIA) TYPE 1B ENDOLEAK. THE PHYSICIANS ELECTED TO PERFORM A SECONDARY INTERVENTION PROCEDURE AND PLACED A 16X27X140 GORE EXCLUDER (NON-ENDOLOGIX) LIMB WHICH SUCCESSFULLY RESOLVED THIS EVENT. IT WAS NOTED THAT THE PATIENT RECEIVED ONE UNIT OF BLOOD AND WAS TAKEN TO THE INTENSIVE CARE UNIT (ICU) POST OPERATIVELY. THE NEXT DAY THE PATIENT WAS TRANSFERRED TO THE TELEMETRY FLOOR AND WAS DISCHARGED ONE DAY LATER. ADDITIONAL INFORMATION: AN INTERNAL CLINICAL ASSESSMENT DETERMINED THAT THERE WAS EVIDENCE TO REASONABLY SUGGEST COILING OF THE INTERNAL MESENTERIC ARTERY OCCURRED (DATE UNKNOWN) OCCURRED THAT WAS NOT INCLUDED IN THE EVENT AS REPORTED. THE COILING WAS DISCOVERED DURING A REVIEW OF THE COMPUTED TOMOGRAPHY (CT) SCAN DATED 05/08/2023.
Patient problems: Abdominal Pain; Aneurysm; Clinical Endoleak; Rupture
MAUDE report 17020506 ↗InjuryMay 10, 2022Off-Label Use; Separation Problem; Off-Label Use; Separation Problem
THE PATIENT WAS IMPLANTED WITH THE AFX2 BIFURCATED STENT GRAFT AND OVATION IX ILIAC LIMB, AFX LIMB STENT GRAFT, AND AN AFX VELA SUPRARENAL TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). THIS INITIAL PROCEDURE IS OUTSIDE THE INDICATIONS OF USE (OFF-LABEL) DUE TO THE USE OF ADJUNCTIVE DEVICES NOT COMPATIBLE WITH AFX SYSTEM PER THE IFU. APPROXIMATELY (3) THREE YEARS AFTER POST INITIAL PROCEDURE, THE PATIENT WAS IDENTIFIED WITH SAC GROWTH IN RIGHT COMMON ILIAC (RCIA) AND A 3A ENDOLEAK WITH SEPARATION BETWEEN THE OVATION IX ILIAC LIMB AND THE AFX2 BIFURCATED STENT GRAFT. A RE-INTERVENTION WAS COMPLETED. THE PHYSICIAN IMPLANTED (2) TWO AFX LIMB STENT GRAFTS TO RESOLVED THE ENDOLEAK. THE FINAL PATIENT STATUS WAS REPORTED TO BE DOING WELL POST RE-INTERVENTION.
Patient problems: Aneurysm; Failure of Implant
MAUDE report 14349995 ↗InjurySep 17, 2021Patient-Device Incompatibility; Migration; Patient-Device Incompatibility; Migration
THE PATIENT WAS INITIALLY IMPLANTED WITH AN OVATION IX STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY THREE (3) MONTHS POST INITIAL PROCEDURE, THE PATIENT PRESENTED AT ROUTINE FOLLOW-UP WITH MIGRATION OF THE LEFT ILIAC LIMB AND A TYPE 1B ENDOLEAK. THE PHYSICIAN SUCCESSFULLY TREATED THE PATIENT BY IMPLANTING TWO (2) OVATION IX ILIAC LIMBS AND THE PATIENT IS REPORTEDLY IN GOOD CONDITION. NOTE: THE PATIENT'S LEFT ILIAC ARTERY IS SHORT AND TAPERED. ADDITIONAL INFORMATION: AN INTERNAL CLINICAL ASSESSMENT DETERMINED THAT THERE WAS EVIDENCE TO REASONABLY SUGGEST A TYPE 2 ENDOLEAK (NON-DEVICE-RELATED) OF THE LUMBAR ARTERY.
Patient problems: Failure of Implant
MAUDE report 12491341 ↗InjuryFeb 27, 2017Occlusion Within Device; Improper or Incorrect Procedure or Method; Malposition of Device; Occlusion Within Device; Improper or Incorrect Procedure or Method; Malposition of Device
AN OVATION IX ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE 5 MONTH POST-OPERATIVE CT IMAGING SHOWED THE PRESENCE OF AN OCCLUSION OF THE RIGHT ILIAC LIMB STENT GRAFT DUE TO THE MALPOSITION OF THE ILIAC LIMB STENT GRAFTS WITHIN THE LEG OF THE AORTIC BODY STENT GRAFT IN COMBINATION WITH THE PRESENCE OF SIGNIFICANT INFRARENAL AORTIC ANGULATION. A RE-INTERVENTION IS PLANNED AT A LATER DATE TO TREAT THE OCCLUDED LIMB. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED AND THE PATIENT WILL CONTINUE TO BE MONITORED.
Patient problems: Occlusion
MAUDE report 6363012 ↗InjuryMar 3, 2016Improper or Incorrect Procedure or Method; Adverse Event Without Identified Device or Use Problem; Improper or Incorrect Procedure or Method; Adverse Event Without Identified Device or Use Problem
AN OVATION IX ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE ANEURYSM WAS SUCCESSFULLY EXCLUDED AT THE CONCLUSION OF THE IMPLANT PROCEDURE. THE 1 MONTH POST-OPERATIVE CT SHOWED THE PRESENCE OF A LEFT INTERNAL ILIAC ARTERY OCCLUSION DUE TO PARTIAL COVERAGE OF THE INTERNAL ILIAC ARTERY WITH THE DISTAL ASPECT OF THE ILIAC LIMB STENT GRAFT. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Occlusion
MAUDE report 5478483 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page